Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
免疫球蛋白体细胞高频突变对弥漫性大B细胞淋巴瘤（DLBCL）具有临床意义，并可能对免疫检查点阻断和基于新抗原的免疫疗法产生影响。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0730-x
Xu-Monette, Zijun Y; Li, Jianyong; Xia, Yi; Crossley, Beryl; Bremel, Robert D; Miao, Yi; Xiao, Min; Snyder, Thomas; Manyam, Ganiraju C; Tan, Xiaohong; Zhang, Hongwei; Visco, Carlo; Tzankov, Alexandar; Dybkaer, Karen; Bhagat, Govind; Tam, Wayne; You, Hua; Hsi, Eric D; van Krieken, J Han; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Piris, Miguel A; Winter, Jane N; Medeiros, Jeffrey T; Xu, Bing; Li, Yong; Kirsch, Ilan; Young, Ken H
